Results for this period
Interim period (second quarter)21 January 2026–20 July 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue increased in the overseas beverage business due to growth in sales volume and sales value in the Turkish beverage business, while a decline in the number of operating vending machines in Japan, lower orders in the pharmaceutical-related business and lower sales volume in the food business reduced revenue. Operating profit increased due to lower depreciation and amortization following the impairment loss recognized in the previous fiscal year, cost controls resulting from profitability improvements, the positive effect of higher revenue in the overseas beverage business, and improvements in the product mix and production efficiency.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 21 January 2026–20 July 2026 |
| Net Sales | ¥120,057 million (YoY +2.0%) |
| Operating profit | ¥6,744 million (YoY +388.2%) |
| Ordinary income | ¥4,331 million |
| Profit attributable to owners of the parent | ¥2,800 million |
| Net income per share | ¥88.34 |
| Equity ratio | End of the current fiscal period 41.5 / End of previous period 39.5 |
| Total assets | ¥166,402 million |
| Net assets | ¥69,769 million |
| Cash flows from operating activities | ¥1,877 million |
| Cash flows from investing activities | ¥-2,844 million |
| Cash flows from financing activities | ¥-3,428 million |
| Cash and cash equivalents at end of period | ¥23,332 million |
| Full-year earnings forecast | Net Sales ¥246,300 million (YoY +2.1%) / Operating profit ¥12,300 million (YoY +195.5%) / Ordinary income ¥9,400 million (YoY +540.7%) / Net income ¥6,000 million |
| Revision to Earnings Forecast | Net Sales ¥246,800 million → ¥246,300 million（-0.2%） / Operating profit ¥10,500 million → ¥12,300 million（+17.1%） / Ordinary income ¥8,400 million → ¥9,400 million（+11.9%） / Net income ¥5,000 million → ¥6,000 million（+20.0%） |
| Annual Dividend Forecast | ¥30 → ¥30（0.0%） |
| Segment revenue | Domestic Beverage Business ¥67,618 million (YoY -5.5%), Overseas beverage business ¥36,029 million (YoY +25.3%), Pharmaceutical-Related Businesses ¥6,540 million (YoY -6.4%), Food Business ¥9,517 million (YoY -8.5%), Orphan-drug business ¥473 million (YoY +79.8%) |
| Segment profit | Domestic Beverage Business ¥2,114 million, Overseas beverage business ¥5,228 million (YoY +68.1%), Pharmaceutical-Related Businesses ¥267 million (YoY -42.2%), Food Business ¥35 million (YoY -93.2%), Orphan-drug business ¥-80 million |
| Depreciation and amortization | ¥2,788 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Added: 0 companies; excluded: 0 companies (company names not disclosed) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (online, for analysts and investors) |
| Issued Shares at Period-End | 33,137,000 shares |
| Treasury Shares at Period-End | 1,429,763 shares |
| Factors Behind Changes in Business Performance | Revenue increased in the overseas beverage business due to growth in sales volume and sales value in the Turkish beverage business, while a decline in the number of operating vending machines in Japan, lower orders in the pharmaceutical-related business and lower sales volume in the food business reduced revenue. Operating profit increased due to lower depreciation and amortization following the impairment loss recognized in the previous fiscal year, cost controls resulting from profitability improvements, the positive effect of higher revenue in the overseas beverage business, and improvements in the product mix and production efficiency. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The interim-period increase in profit was driven by higher revenue and expanded profitability in the overseas beverage business, centered on the Turkish beverage business, lower depreciation and amortization following the impairment loss recognized in the previous fiscal year, and measures to improve profitability in the domestic beverage business. The revisions to the full-year forecast incorporate rising costs due to the situation in the Middle East, marketing investment in Turkey, the continuation of profitability improvement measures in the domestic beverage business, and revised assumptions for Turkey's inflation rate and foreign exchange rates.